SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Overview Fund Activity
Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

50 hedge funds and large institutions have $52.2M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 9 closing their positions.

Holders
50
Holders Change
+5
Holders Change %
+11.11%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
16
Reduced
10
Closed
9
Calls
$84K
Puts
$48K
Net Calls
+$36K
Net Calls Change
+$282K

Top Buyers

1
BCM
1
Bridgeway Capital Management
Texas
$552K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$394K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.95M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.46M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$328K

Top Sellers

1
American Century Companies
1
American Century Companies
Missouri
$0
2
MIM
2
Monashee Investment Management
Massachusetts
$0
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$0
4
Millennium Management
4
Millennium Management
New York
$103K
5
Morgan Stanley
5
Morgan Stanley
New York
$1.09M
Name Holding Trade Value Shares
Change 		Shares
Change %
WP
51
Woodline Partners
California
– -$193K -2,631 Closed
Squarepoint
52
Squarepoint
New York
– -$120K -1,633 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
– -$107K -1,463 Closed
Jane Street
54
Jane Street
New York
– -$77K -1,049 Closed
PHK
55
Point72 Hong Kong
Hong Kong
– -$4K -49 Closed
1 2
3